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Abstract
Background: The mammary gland is a conserved site of lipoprotein lipase expression across species and lipoprotein lipase
attachment to the luminal surface of mammary gland vascular endothelial cells has been implicated in the direction of
circulating triglycerides into milk synthesis during lactation.
Principal Findings: Here we report generation of transgenic mice harboring a human lipoprotein lipase gene driven by a
mammary gland-specific promoter. Lipoprotein lipase levels in transgenic milk was raised to 0.16 mg/ml, corresponding to
an activity of 8772.95 mU/ml. High lipoprotein lipase activity led to a significant reduction of triglyceride concentration in
milk, but other components were largely unchanged. Normal pups fed with transgenic milk showed inferior growth
performances compared to those fed with normal milk.
Conclusion: Our study suggests a possibility to reduce the triglyceride content of cow milk using transgenic technology.
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Introduction
Lipoprotein lipase (LPL) plays a pivotal role in the transportation
and energy metabolism of plasma lipoprotein, because it catalyzes
the hydrolysis of the triglycerides (TG) circulating in chylomicrons
and very low density lipoproteins (VLDL) into glycerol and non-
esterified fatty acids (NEFA) [1,2]. Functional LPL is anchored to
the luminal surface of the capillary endothelium, where it is
synthesized by parenchymal cells of adipose tissue, muscle, heart
and the lactating mammary gland (MG). Recent study shows that a
glycol protein, glycosylphosphatidylinositol- anchored high-density
lipoprotein binding protein1 (GPIHBP1), also participates in the
transport of LPL into capillaries via avid LPL binding [3].
Production of milk lipids by maternal MG in the mouse is
equivalent to its entire body weight (BW) during a single lactation
cycle (20 days) [4]. TG constitute 98% of milk lipid content and the
4% fat found in human milk provide 40–50% of total ingested
calories [5]. Milk lipids are a vital source of energy and play an
important role in the growth and development of mouse pups. TG
cannot cross the capillary endothelium of most tissues, which suggests
that LPL is involved in the uptake of blood TG by capillaries of
mammary tissue for milk fat production [6] and that LPL activity
levels reflect its capacity to direct TG from the blood [7]. Milk LPL is
considered to be a spillover from MG and LPL activity in milk might
indicate LPLactivity inthe MG. LPLactivity in human milkis 200 n-
equiv of fatty acid/min per ml, whereas the LPL activity level is 20-
fold higher in mouse milk and six-fold higher in bovine milk [8].
Transgenic murine models have been widely used to study the
tissue-specific function of LPL. Generalized over-expression of
human LPL (hLPL) improved postheparin plasma LPL activity and
reduced plasma TG in mice [9] [10,11]. Transgenic mice that over-
expressed LPL in skeletal muscle showed reduced plasma TG levels.
Most of these mice exhibited weight loss [12,13], but some
maintained normal growth [14], insulin resistance was also observed
[15,16]. There are no previous reports of LPL over-expression in
MG, which is the major tissue in production of milk lipids during
lactation. We therefore aimed to establish a transgenic mouse model
expressing human LPL(hLPL) in the MG. Thismodel might be used
to investigate the function of LPLin the MG and to evaluate potential
applications in obtaining a low TG content cow milk in the future.
Results
Generation and Characterization of Transgenic Mice
Transgenic mice expressing milk hLPL were generated by
inserting an hLPL cDNA into a pBC1 vector controlled by the
MG-specific goat b-casein promoter (Figure 1A). Previous studies
successfully used the pBC1 vector for high-level expression of the
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(five females and three males) were identified initially by PCR and
confirmed by Southern blot (Figure 1B). Further analysis showed
that these transgenic founders habored different copy numbers of
the transgene. Lines hLPL-11 (1), -16 (2), -17 (2) had only a few
copies (one or two), whereas lines hLPL-21 (6), -25 (4), -27 (10), -31
(22), -37 (11) contained more copies ($4). Copy numbers of the
transgene varied from one to 22 copies per cell in founder lines.
We verified tissue-specific expression of hLPL controlled by the
goat b-casein promoter by examining tissues taken from transgenic
and wide type (WT) mice after 8 to 12 days of lactation, using RT-
PCR. As expected, hLPL mRNA was detected in the MG of
transgenic mice during the middle of the lactation period, but not
in other tissues (Figure 1C). Western blot was further employed to
detect recombinant hLPL in transgenic milk using an hLPL
specific mouse monoclonal antibody (5D2). Milk samples were
collected from five lines (hLPL-21, -25, -27, -31 and -37) of female
transgenic founders during the middle lactation. Milk from all five
transgenic founders contained the expected band of about
56 KDa, which is the molecular weight (MW) of native hLPL
found in human milk (Figure 1D). hLPL was undetectable in milk
of WT mice.
LPL Concentration and Activity Assay
The ELISA kit we used did not specify whether it can
distinguish recombinant human LPL from endogenous mouse
LPL. We therefore compared the total LPL protein content in the
milk between transgenic (n=10) and WT mice (n=6, Table 1). As
such, LPL protein content in transgenic milk showed an
approximately five- to six-fold increase, compared with control
milk, during the different lactation stages. The highest level of LPL
found in transgenic colostrum was 0.16 mg/ml. In general, LPL
activity was high in the colostrum, but fell off during the lactation.
There was 1.7-fold increase in LPL activity in transgenic milk at
early lactation, 2-fold at middle lactation and 2.5-fold at late
lactation, when compared with WT milk.
Figure 1. Generation and molecular characterization of transgenic mice. (A) hLPL cDNA (3.3 kb) was inserted into a backbone isolated from
pBC1 using Not I/Sal I. The backbone included 26chicken b-globin insulator, goat b-casein promoter, untranslated exons E1, parts of E2 and 7, E8, E9
and b-casein 39 genomic DNA. hLPL cDNA was located between E2 and E7, flanked by two Xho I restriction sites. The translation initiation and
termination sites are indicated as ATG and TGA. (B) Southern blot identification of transgenic mice. Digested genomic DNA of eight transgenic
founders and WT mice hybridized with a 1.1 kb PCR labeled hLPL cDNA. An expected 1.1 kb band was detected in transgenic samples. WT, wild type
mouse genomic DNA. P1, P5, P10 represent 1, 5 and 10 copies of hLPL cDNA plasmid, respectively. (C) RT-PCR analysis of hLPL expression in
transgenic mice. All tissue RNAs used for RT-PCR were collected during the middle of the lactation period. Mouse b-actin was used as the RT-PCR
internal control. M, 1 kb ladder; WT, wild type mouse mammary gland; MG, transgenic mouse mammary gland; H, heart; L, liver; S, spleen; Lu, lung;
Mu, muscle; A, adipose tissue. (D) Western blot analysis of hLPL expression in milk of transgenic mice. The milk samples were collected during the
middle of the lactation period, separated by SDS-PAGE and then transferred to nitrocellulose membranes. WT, milk from wild type mice (negative
control); H, human milk (positive control); milk from transgenic founders numbered hLPL-21, -25, -27,-31 and -37.
doi:10.1371/journal.pone.0020895.g001
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Total Protein or Lactose Content
Milk samples were further analyzed for TG, total protein and
lactose content. TG level in transgenic milk was significantly lower
(nearly half) than WT milk throughout lactation (Figure 2A),
which suggested a strong correlation between TG concentrations
and LPL activity in the milk (Figure 2B). Analysis of milk
composition revealed no change in lactose or total protein levels
(Table 2).
Free Fatty Acid Content in Milk and Serum
TG concentrations in the milk of transgenic mice decreased
significantly compared with WT milk, so we determined whether
reduced TG was hydrolyzed to FFA before being secreted into
milk. Milk samples from all three stages of lactation were measured
for FFA content. Quite unexpectedly, no significant difference of
FFA content was observed between transgenic and WT milk
(Figure S1). Levels of FFA in the serum were indistinguishable
between transgenic and WT dams at middle lactation. We also
analyzed the fatty acid composition of these milk samples, but
found no different fatty acid carbon ratio between transgenic and
WT milk throughout lactation (Figure S2).
Growth Delay of Pups Fed by Transgenic Milk
In the early stage of this study, we noted that before weaning,
pups reared by transgenic females seemed to grow more slowly
independent of their genotypes (transgene or WT) compared with
those reared by WT females. This indicated that the compositional
change of transgenic milk might influence pup growth. We
investigated this finding further using transgenic and WT dams,
which were used to rear fostered newborns. This design was
employed to exclude the influence of genetic background on
growth. BW of pups selected at birth was approximately 2 g.
Newborn pups from the same litter were divided into two halves,
with one-half used for rearing by transgenic dams and the other by
WT dams. In total six dams (three transgenic dams and three WT
dams) were used in the experiment and each nursing dam was
allowed to raise eight to ten pups.
There was a significant difference in BW after 5 days between
pups reared by LPL (transgenic) and WT dams. Compared to
pups nursed by WT dams (WT pups), pups nursed by LPL dams
(LPL pups) showed retarded growth and their BW was always
lower prior to weaning. At day 21 of lactation, the BW of LPL
pups was approximately 10.18 g, which was 72.8% of WT pups
BW (Figure 3). The difference between the heaviest and the
lightest pups was 8 g. Maternal milk is the only nutrient source for
suckling pups, so the great difference in pup BW must be
attributable to differences in milk composition.
The most striking differences between transgenic and WT milk
were LPL and TG concentrations, so either change might account
for the observed differences in pup growth. To further address this
issue, the gastric content of pups (3 days after birth) was tested to
Table 1. LPL concentrations and activity in the milk of
transgenic and WT mice during different lactation stages.
LPL protein (mg/ml) LPL activity (mU / ml)
WT(n=6) hLPL(n=10) WT(n=6) hLPL(n=10)
Early
lactation
23.0361.77 152.3067.70*** 4013.306625.88 6923.3061849.63*
Middle
lactation
19.7362.94 148.6065.86*** 2914.826702.93 5872.9661913.60*
Late
lactation
21.6561.60 127.91622.24*** 1993.466270.77 4922.8062018.19*
*P,0.05;
***P,0.001. All values represent means 6 SD. n=number of animals.
doi:10.1371/journal.pone.0020895.t001
Figure 2. Change of TG concentration in transgenic milk. (A) TG
content in milk of transgenic and WT mice during different lactation
stages. Ten transgenic mice and six WT mice were tested. Bars represent
mean (SD). (* P,0.05, *** P,0.001) (B) Correlation of TG concentration
and LPL activity in milk of transgenic and WT mice during different
lactation stages. (rho=0.725 P,0.0001) [Data tested using Spearman’s
Rank test].
doi:10.1371/journal.pone.0020895.g002
Table 2. Composition of milk from transgenic and WT mice
during different lactation stages.
(g / L) LPL (n=10) WT (n=6)
Protein Early lactation 107.31635.01 98.55620.66
Middle lactation 95.21631.91 93.36644.33
Late lactation 101.12618.80 116.9367.87
Triglyceride Early lactation 190.88629.24*** 352.84665.99
Middle lactation 182.59639.70*** 318.54684.23
Late lactation 199.37662.23* 272.67634.89
Lactose Early lactation 15.4064.60 16.3664.50
Middle lactation 11.6264.25 9.7064.34
Late lactation 13.3665.13 13.3864.91
*P,0.05;
***P,0.001. All values represent means 6 SD. n=number of animals.
doi:10.1371/journal.pone.0020895.t002
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six hours, and then reunited. Five minutes after pups began to suck
milk, we collected milk curds in the stomach of pups to measure
LPL activity. LPL activity for five LPL pups was 2.1, 5.6, 0, 1.0,
0 mU/mg, LPL activity for five WT pups was 1.0, 2.0, 0, 0,
0 mU/mg. This suggests that little LPL activity could be detected
in the stomach of pups regardless of they were fed with transgenic
or WT milk. Low pH conditions in the stomach probably led to
LPL losing its activity. Our results strongly suggest that the
retarded growth of pups fed by transgenic dams was due to the
significant reduction of TG content.
Pup serum was collected to detect levels of TG, CHO and FFA
at day 3, 10, and 20. As shown in Table 3, the TG level for LPL
pups at day 3, day 10 and day 20, was 76.4%, 121% and 110%,
respectively compared with WT pups. At day 10, the CHO level
for LPL pups were 65.4% compared to WT pups. At day 3 and
day 20, there were no significant differences in CHO levels
between LPL pups and WT pups. We found no significant
differences in FFA level between LPL pups and WT pups. Thus
we found no pattern in the variation of fasting TG, CHO and FFA
levels in LPL pups compared with the controls.
Nutrients in the Feces of Pups
Feces were collected and analyzed for loss of nutrients from
suckling pups. Figure 4 showed that crude protein levels were
1.02% to 1.10% for LPL pups and 1.60% to 1.92% for WT pups.
Crude fat levels were 2.23% to 2.31% for LPL pups and 3.00% to
3.70% for WT pups. There was no significant difference in dry
matter content between the two groups.
Discussion
There are two putative sources of milk LPL. Firstly, LPL might
be derived from tissues such as adipose tissue that secrete LPL
from parenchymal cells before being transferred to milk [19].
Previous researches argued that if this was a viable route it might
contribute little to milk LPL constitution [7]. Secondly, LPL
derived from MG could be secreted into milk and also migrate
through the basal membrane into the blood circulation. We found
no hLPL in transgenic maternal serum by western blotting.
However, the perennial argument about whether LPL is
synthesized by the adipocytes or the epithelial cells of lactating
MG was unresolved [20,21]. We used an MG-specific promoter in
this study to express protein exclusively in mammary epithelial
cells and our results suggested that mammary epithelial cells can
synthesize biologically active LPL. According to our result
(Table 1), LPL mass in transgenic milk increased five- to six-fold
compared to that in control milk, while LPL activity was only
about doubled during various lactation stages. There is then a big
drop in LPL specific activity in transgenic milk. This is most likely
caused by the antibodies in the Elisa kit which have higher affinity
towards exogenous human LPL than towards endogenous mouse
LPL. Therefore, even though the real protein levels of exogenous
human LPL might be similar to endogenous mouse LPL, the
actual readings of human LPL protein levels would be much
higher measured by this kit. However, the possibility that some
inactive human LPL might be produced by transgenic mice can
not be ruled out.
An interesting observation in this study was that the increased
hLPL expression led to a dramatic reduction of TG content in the
milk. The mechanism underlying this observation is not clear and
might be explained by two possibilities. One is that hLPL
produced by the transgenic mice competes with endogenous
mouse LPL the binding sites at GPIHBP1 which is responsible for
the transport of LPL into capillaries [6], leading to a limited
capacity to transport LPL to the vascular endothelium where it
directs the movement of fatty acid into the mammary cells. The
other explanation would be that the over-expressed hLPL is able
to hydrolyze the TG as it has been known that the LPL in goat
milk can act on TG due to its presence in fat globule [22]. Hence,
TG hydrolysis should occur around MG epithelial cells because
this is the site of hLPL and TG synthesis in our transgenic mice. If
this is the case, then we need to determine the destination of the
Figure 3. Growth curve of pups nursed from birth to day 21 by nursing mothers. Only litters of nursing dams which suckled newborns
regularly were used in the statistical study. Body weight of each pup was weighed in the morning daily, from birth until weaning. Data were derived
from a total of 30 WT pups belonging to three litters fed by three WT dams and 28 WT pups arising from three litters fed by three LPL dams. Error bars
represent mean (SD).
doi:10.1371/journal.pone.0020895.g003
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destinations; 1) secretion into milk and 2) entering maternal
circulating blood. However, we detected no significant differences
in the FFA content and FA composition of milk or maternal serum
between transgenic mice and WT controls. FFA released by LPL
hydrolysis appears to follow concentration gradients during
transport [23] and is preferentially esterified for storage by tissues,
or oxidized to provide an alternative energy source compared with
plasma NEFAs [24]. It is probable that the FFA hydrolysis
products of TG enter the maternal blood circulation and then are
used for metabolism.
There is some controversy over whether milk LPL has a
function in infant fat digestion. Previous researchers suggest
that milk fat is not a good substrate for LPL, and LPL activity is
also inhibited by bile salts in infants. Opponents of this view
contend that LPL is critical for the assimilation of a high fat
milk diet by suckling young [25]. In our study, LPL activity
could not be detected in the stomach of suckling pups fed by
either transgenic or WT milk. The loss of LPL activity was most
likely due to low stomach pH, because the optimum pH for
LPL activity is pH 8–9.
Fats are high energy sources and have a critical role in the
growth and development of the neonates. Infants consume fats
largely as TG, which are also integral constituents of neural
and retinal tissues. Not surprisingly, low TG content in the
milk caused significant reductions in the BW of suckling pup,
because of a reduced energy supply. Significantly less fat and
protein were found in the feces of LPL pups compared with
WT pups, which might indicate that intestinal absorption of
suckling pups was enhanced by the reduced TG content
of milk.
In summary, we successfully generated transgenic mice that
over-expressed hLPL, specifically in the MG. High LPL activity in
the MG reduced milk TG during lactation. TG content was
significantly reduced in transgenic milk, but the levels of other
nutrients such as protein, lactose, and FA remained the same as
the controls. Our study raises the possibility that low TG cow milk
might be produced in future using the same method.
Materials and Methods
Animals
Kunming white mice (Beijing Laboratory Animal Center, CN)
were used in this study. They were kept under conditions of
regulated temperature (22 to 25uC), humidity (40 to 50%), and
illumination cycles (12 h light, 12 h dark). They were provided
with a standard rodent chow diet (1022 Rat/Mouse Maintenance
Diet, HFK Bio-Technology Co. Ltd, CN) and water ad libitum.B W
of pups was measured daily (from 09:00 to 10:30 h) throughout 21
days of lactation.
Table 3. Triglyceride, cholesterol and free fatty acid concentrations in the serum of pups aged 3 days, 10 days and 20 days which
were nursed with transgenic and WT milk.
WT hLPL
3 days 10 days 20 days 3 days 10 days 20 days
TG (mg/dl) 365.006109.64 245.4642.41 286.5646.13 279.10625.34 297.90621.97* 169.80620.99***
CHO (mg/dl) 170.20610.99 212.50644.33 208.50658.65 195.10623.02 138.90632.46* 158.40612.99
FFA (mEq/L) 316.51676.17 391.20668.89 569.846119.74 470.256153.29 457.566196.70 538.336117.86
*P,0.05;
***P,0.001. All values represent means 6 SD. n=number of animals.
doi:10.1371/journal.pone.0020895.t003
Figure 4. Fat, protein and dry matter measured in feces of suckling pups. Data shown are percentages of the total for the three constituents
in feces. Bars represent mean (SD). (** P,0.01).
doi:10.1371/journal.pone.0020895.g004
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hLPL cDNA was amplified from a plasmid SC120026 (Origene,
MD) by PCR, with Xho I restriction sites added at the 59 end of both
primers. The PCR product (3391 bp) was cloned into a T-vector
and confirmed by sequencing. The cDNA fragment was inserted
into a commercial pBC1 vector (Invitrogen, CA) at the Xho Is i t et o
generate the pBC-hLPL expression vector. pBC-hLPL was digested
with Not Ia n dSal I to release a 19.1 kb linear DNA fragment, then
was purified by agarose gel electrophoresis and electro-elution before
microinjected into pronuclei of fertilized Kunming White mouse
eggs.
Genotyping of Transgenic Mice by PCR and Southern
Blotting
Genomic DNA was isolated from tail tips of 3–4-week-old mice.
The hLPL transgene was detected by PCR, using the upstream
primer 59-GTGGCTACCTGTCATTTCAAT-39 and the down-
stream primer 59-ACAGAGAGTCGATGAAGAG-39, which
yielded a 648 bp product. Eight transgenic mice (five females
and three males) with hLPL cDNA in their genomes were
identified from a sample of 42 mice.
Genomic DNA (15 g) was digested prior to southern blotting
using EcoR I. A 1.1 kb hLPL cDNA fragment was amplified from
the transgene vector (forward primer 59-ATTCTGGATC-
TTTCGGACTGA-39 and reverse primer 59-ATTCCAAGCCT-
GATGATGTTA-39) and used as a probe, which was labeled
using a PCR digoxygenin probe synthesis kit (Roche, CH).
Hybridization and detection methods were conducted in accor-
dance with the manufacturer’s digoxygenin hybridization instruc-
tions. Transgene copy numbers were determined by signal
quantification using a phosphorimager (Storm820; Molecular
Dynamics, Sunnyvale, CA).
RT-PCR
Total RNA was isolated from the MG and other tissues (heart,
liver, spleen, lung, adipose tissue, and muscle) with Trizol reagent
(Tiangen, China). Two primers were used to detect transgene
expression. The forward primer 59-CCATTCAGCTTC-
TCCTTCA-39 was complementary to exon 1 of goat b-casein
on the backbone of pBC1 and the reverse primer 59-AAAT-
CTCTTCTTTGGTCGGC-39 was complementary to the hLPL
coding sequence. The two primers amplified a 250 bp PCR
product. A 142 bp fragment amplified from mouse b-actin was
used as an RT-PCR internal control. The forward primer was 59-
TTCTACAATGAGCTGCGTGTGG-39 and the reverse primer
was 59-GGTGTTGAAGGTCTCAAACATGAT-39.
Milk Nutrient Assay and Western Blot
Maternal mice were anaesthetized with an intraperitoneal
injection of pentobarbital (0.65 mg/10 g body wt.) and a 0.1 unit
of oxytocin was delivered by intracardiac injection. Milk samples
of transgenic mice and non-transgenic mice were collected during
early (day 3–5), middle (day 8–12) and late (day 15–17) lactation.
Milk samples were diluted three times with distilled water and
separated by electrophoresis on 10% SDS-polyacrylamide gels
before transfer to nitrocellulose membranes (Amersham Biosci-
ences, US). Membranes were incubated overnight in blocking
buffer (3% BSA in PBS-T) at 4uC, before immunodetection using
a HRP-conjugated LPL (5D2) mouse monoclonal antibody (Santa
Cruz, US) at a concentration of 1:1000 as specified in the
manufacturer’s protocol.
Milk lactose concentration was determined using an enzymatic
reagent kit (Catalog no. 10986119035) supplied by Boehringer
(GER). Milk protein was measured as carcass protein [26].
Assays for LPL Mass and Activity
Mouse milk LPL concentration was measured using a commer-
cial ELISA kit (Catalog No. L040-90; GBD Ltd., US), according to
the manufacturer’s instructions. Milk LPL was assayed in duplicate,
as previously described [27], using a [
3H] triolein emulsion
substrate. LPL activity of stomach curd milk was also tested using
this method. One milliunit (mU) of lipase activity is equivalent to
1 nmol of free fatty acid (FFA) released per minute at 37uC.
Lipid Analysis
Concentration of TG, cholesterol (CHO) and FFA in milk and
serum was determined using commercial kits (Sigma, USA)
(Catalog no. 99975406 WAKO Chemicals USA, Baltimore,
Md.). Fasting (from 09:00 to 14:00 h) serum was collected for
lipid measurement. Milk fatty acid composition was determined as
previously described (Knapp 1979). All lipid samples contained a
known volume of an internal standard. Results from gas
chromatography were expressed as percentage composition.
Fecal Analysis
Feces were collected from pups fed with WT and transgenic
milk. All fecal samples were dried in a forced air oven (60uC) for
72 h and analyzed for fat, protein and dry matter, according to
AOAC methods (1995).
Supporting Information
Figure S1 FFA concentrations in maternal milk and
serum. (A) FFA content in milk f transgenic and WT mice during
different lactation stages. (B) FFA content in serum of transgenic
and WT dam at middle lactation. Five transgenic and WT dam
respectively were assayed after fasting. Bars represent means (SD).
(TIF)
Figure S2 Fatty acid composition of milk. Data shown are
percentages of the total fatty acid content. The abscissa is on
behalf of carbon ratio. Bars represent means (SD).
(TIF)
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